EXHIBIT 31.1

                    CERTIFICATION OF CHIEF EXECUTIVE OFFICER
                PURSUANT TO THE SECURITIES EXCHANGE ACT OF 1934,
                             RULES 13A-14 AND 15D-14
                             AS ADOPTED PURSUANT TO
                  SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

         In connection with the Quarterly Report of Remedent USA, Inc. (the
"Company") on Form 10-QSB for the period ending June 30, 2004 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Robin
List, Chief Executive Officer of the Company, certify, pursuant to Rules 13a-14
and 15-d14 of the Securities Exchange Act of 1934 (the "Exchange Act"), as
adopted pursuant to ss.302 of the Sarbanes-Oxley Act of 2002, that:

(1)   I have reviewed this Report;

(2)   Based on my knowledge, this Report does not contain any untrue statement
      of a material fact or omit to state a material fact necessary to make the
      statements made, in light of the circumstances under which such statements
      were made, not misleading with respect to the period covered by this
      Report;

(3)   Based on my knowledge, the financial statements, and other financial
      information included in this Report, fairly present in all material
      respects the financial condition, results of operations and cash flows of
      the Company, as of, and for, the periods presented in this Report;

(4)   I and the other certifying officers of the Company are responsible for
      establishing and maintaining disclosure controls and procedures (as
      defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and
      have:

      a.    Designed such disclosure controls and procedures, or caused such
            disclosure controls and procedures to be designed under our
            supervision, to ensure that material information relating to the
            Company, including any consolidated subsidiaries, is made known to
            us by others within those entities, particularly during the period
            in which this Report is being prepared; b. Evaluated the
            effectiveness of the Company's disclosure controls and procedures
            and presented in this Report our conclusions about the effectiveness
            of the disclosure controls and procedures, as of the end of the
            period covered by this Report based on such evaluation; and c.
            Disclosed in this Report any change in the Company's internal
            control over financial reporting that occurred during the Company's
            most recent fiscal quarter (the Company's fourth fiscal quarter in
            the case of an annual report) that has materially affected, or is
            reasonably likely to materially affect, the Company's internal
            control over financial reporting; and

(5)   I and the other certifying officers have disclosed, based on our most
      recent evaluation of internal control over financial reporting, to the
      Company's auditors and to the audit committee of the Company's board of
      directors (or persons performing the equivalent functions):

      a.    All significant deficiencies and material weaknesses in the design
            or operation of internal control over financial reporting which are
            reasonably likely to adversely affect the Company's ability to
            record, process, summarize and report financial information; and

      b.    Any fraud, whether or not material, that involves management or
            other employees who have a significant role in the Company's
            internal control over financial reporting.


  /S/ ROBIN LIST
--------------------------------
Robin List,
Chief Executive Officer
August 12, 2004